<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Stock Blog Hub &#187; CMS Energy Corporation</title>
	<atom:link href="http://www.stockbloghub.com/tag/cms-energy-corporation/feed" rel="self" type="application/rss+xml" />
	<link>http://www.stockbloghub.com</link>
	<description>Start Your Investing Research Here!</description>
	<lastBuildDate>Tue, 22 May 2012 18:53:06 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.2</generator>
		<item>
		<title>(MRGE) Merge Healthcare Unveils Cloud-based Platform</title>
		<link>http://www.stockbloghub.com/2011/11/30/mrge-merge-healthcare-unveils-cloud-based-platform/87703</link>
		<comments>http://www.stockbloghub.com/2011/11/30/mrge-merge-healthcare-unveils-cloud-based-platform/87703#comments</comments>
		<pubDate>Wed, 30 Nov 2011 19:58:00 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare Information Services]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[CMS]]></category>
		<category><![CDATA[CMS Energy Corporation]]></category>
		<category><![CDATA[DELL]]></category>
		<category><![CDATA[Dell Inc.]]></category>
		<category><![CDATA[GE]]></category>
		<category><![CDATA[General Electric Company]]></category>
		<category><![CDATA[HIT]]></category>
		<category><![CDATA[Hitachi Limited]]></category>
		<category><![CDATA[MCK]]></category>
		<category><![CDATA[McKesson Corporation]]></category>
		<category><![CDATA[Merge Healthcare Incorporated.]]></category>
		<category><![CDATA[MRGE]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=87703</guid>
		<description><![CDATA[Recently, Merge Healthcare (MRGE) showcased its new cloud-based platform ‘Merge Honeycomb’ along with its first application in the cloud, namely ‘free image sharing’ at the Radiological Society of North America (RSNA). This application enables users to upload, download, view and share medical images everywhere without the help of any additional software. Through this new solution the company intends to improve image interoperability and achieve the ‘Meaningful Use’ stamp from the federal government. Earlier this month, Merge selected Dell, Inc (DELL) as its preferred cloud computing services provider. The company expects to launch “Merge Honeycomb” in the first quarter of 2012, which led to a 17.5% increase in the stock price to $5.18 on Monday. Presently, Merge boasts the largest image sharing network opportunity with 6,000 clinics across the US, This ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/11/30/mrge-merge-healthcare-unveils-cloud-based-platform/87703/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(DNDN) Dendreon Loss Narrows</title>
		<link>http://www.stockbloghub.com/2011/11/06/dndn-dendreon-loss-narrows/86549</link>
		<comments>http://www.stockbloghub.com/2011/11/06/dndn-dendreon-loss-narrows/86549#comments</comments>
		<pubDate>Sun, 06 Nov 2011 19:55:48 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[CMS]]></category>
		<category><![CDATA[CMS Energy Corporation]]></category>
		<category><![CDATA[Dendreon Corporation]]></category>
		<category><![CDATA[DNDN]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[MDVN]]></category>
		<category><![CDATA[Medivation Inc]]></category>
		<category><![CDATA[Merck & Company Inc]]></category>
		<category><![CDATA[MRK]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=86549</guid>
		<description><![CDATA[Dendreon Corporation (DNDN) reported third-quarter 2011 loss (including stock-based compensation expense but excluding other special items) of 67 cents per share, which was narrower than the Zacks Consensus Estimate of 70 cents due to a slightly better-than-expected performance of its prostate cancer vaccine Provenge in the quarter. Loss was, however, much wider than the year-ago loss of 54 cents per share. Quarterly Details Total revenue in the reported quarter climbed to $64.3 million (including rebates and charge-backs) from $20.2 million in the comparable quarter of 2010. The jump was attributable to the higher Provenge revenue in the current quarter versus low Provenge sales in the third quarter of 2010 as it was only the second quarter of its launch. Revenues were also above the Zacks Consensus Estimate of $63 million. ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/11/06/dndn-dendreon-loss-narrows/86549/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(EW) Edwards Lifesciences 2011 Fourth Quarter Earnings Scorecard</title>
		<link>http://www.stockbloghub.com/2011/10/31/ew-edwards-lifesciences-2011-fourth-quarter-earnings-scorecard/86162</link>
		<comments>http://www.stockbloghub.com/2011/10/31/ew-edwards-lifesciences-2011-fourth-quarter-earnings-scorecard/86162#comments</comments>
		<pubDate>Mon, 31 Oct 2011 15:47:29 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[Boston Scientific Corporation]]></category>
		<category><![CDATA[BSX]]></category>
		<category><![CDATA[CMS]]></category>
		<category><![CDATA[CMS Energy Corporation]]></category>
		<category><![CDATA[Edwards Lifesciences Corporation]]></category>
		<category><![CDATA[EW]]></category>
		<category><![CDATA[MDT]]></category>
		<category><![CDATA[Medtronic Inc]]></category>
		<category><![CDATA[NCA]]></category>
		<category><![CDATA[Nuveen California Municipal Value Fund Inc]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=86162</guid>
		<description><![CDATA[The announcement of Edwards Lifesciences’ (EW) third quarter fiscal 2011 results as on October 19, 2011, has led analysts to revise their estimates lower for the fourth quarter and fiscal 2011. Third Quarter Highlights Edwards reported an adjusted EPS of 38 cents in the third quarter of fiscal 2011, a penny below the Zacks Consensus Estimate, and missing the year-ago quarter’s adjusted EPS of 43 cents. Revenues increased 18.3% to $412.7 million, exceeding the Zacks Consensus Estimate of $405 million. Heart Valve Therapy remained the strongest segment at Edwards with an annualized growth of 22.7% to reach $246.1 million. Sales of surgical heart valves grew 7.7% to $163.5 million and transcatheter heart valves (THV) catapulted 69.1% to book $82.6 million. The other segments of the company, namely Critical Care, Cardiac Surgery ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/10/31/ew-edwards-lifesciences-2011-fourth-quarter-earnings-scorecard/86162/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(EW) Edwards Lifesciences Corporation Earnings Preview</title>
		<link>http://www.stockbloghub.com/2011/10/18/ew-edwards-lifesciences-corporation-earnings-preview/85251</link>
		<comments>http://www.stockbloghub.com/2011/10/18/ew-edwards-lifesciences-corporation-earnings-preview/85251#comments</comments>
		<pubDate>Tue, 18 Oct 2011 17:11:23 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[ACC]]></category>
		<category><![CDATA[American Campus Communities Inc]]></category>
		<category><![CDATA[Boston Scientific Corporation]]></category>
		<category><![CDATA[BSX]]></category>
		<category><![CDATA[CMS]]></category>
		<category><![CDATA[CMS Energy Corporation]]></category>
		<category><![CDATA[Edwards Lifesciences Corporation]]></category>
		<category><![CDATA[EW]]></category>
		<category><![CDATA[MDT]]></category>
		<category><![CDATA[Medtronic Inc]]></category>
		<category><![CDATA[NCA]]></category>
		<category><![CDATA[Nuveen California Municipal Value Fund Inc]]></category>
		<category><![CDATA[STS]]></category>
		<category><![CDATA[Supreme Industries Inc]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=85251</guid>
		<description><![CDATA[Edwards Lifesciences Corporation (EW) is scheduled to release its third quarter fiscal 2011 results on Wednesday, October 19, 2011 after the market closes. The company is expected to earn 39 cents per share during the quarter on $405 million in revenues, according to the Zacks Consensus Estimate. The consensus estimate is lower that the year-ago quarter’s EPS of 43 cents. As per Edwards’ guidance (provided along with the second quarter results), adjusted EPS is expected in the range of 37?39 cents. Previous Quarter Highlights Edwards reported an adjusted EPS of 49 cents in the second quarter of fiscal 2011, a penny below the Zacks Consensus Estimate, although exceeding the year-ago quarter’s adjusted EPS of 46 cents. Revenues increased 18.1% to $431.2 million, also ahead of the Zacks Consensus Estimate of ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/10/18/ew-edwards-lifesciences-corporation-earnings-preview/85251/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(EW) Edwards Lifesciences Announces Share Buyback</title>
		<link>http://www.stockbloghub.com/2011/10/06/ew-edwards-lifesciences-announces-share-buyback/84653</link>
		<comments>http://www.stockbloghub.com/2011/10/06/ew-edwards-lifesciences-announces-share-buyback/84653#comments</comments>
		<pubDate>Thu, 06 Oct 2011 15:24:51 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[Boston Scientific Corporation]]></category>
		<category><![CDATA[BSX]]></category>
		<category><![CDATA[CMS]]></category>
		<category><![CDATA[CMS Energy Corporation]]></category>
		<category><![CDATA[Edwards Lifesciences Corporation]]></category>
		<category><![CDATA[EW]]></category>
		<category><![CDATA[MDT]]></category>
		<category><![CDATA[Medtronic Inc]]></category>
		<category><![CDATA[NCA]]></category>
		<category><![CDATA[Nuveen California Municipal Value Fund Inc]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=84653</guid>
		<description><![CDATA[Edwards Lifesciences Corporation (EW) recently announced a new share repurchase program worth $500 million. At the end of the second quarter of fiscal 2011, the company was left with $240 million of authorization. Edwards expects to repurchase approximately $100 million worth of additional shares during the third quarter of the current fiscal. Edwards exited the second quarter of fiscal 2011 with $468.2 million in cash and cash equivalents (up from $396.1 million at the end of December 2010) and total debt of $174.8 million. Free cash flow generated during the quarter was $42.1 million and the company anticipates it to be within the $190?$200 million level for the year. Moreover, 970,000 shares for $83.2 million were repurchased during the most recent quarter. While the latest share buyback program is an ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/10/06/ew-edwards-lifesciences-announces-share-buyback/84653/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(EW) Edwards Lifesciences Sapien Under Centers for Medicare &amp; Medicaid Services NCA</title>
		<link>http://www.stockbloghub.com/2011/10/02/ew-edwards-lifesciences-sapien-under-centers-for-medicare-medicaid-services-nca/84430</link>
		<comments>http://www.stockbloghub.com/2011/10/02/ew-edwards-lifesciences-sapien-under-centers-for-medicare-medicaid-services-nca/84430#comments</comments>
		<pubDate>Sun, 02 Oct 2011 20:13:45 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[ACC]]></category>
		<category><![CDATA[American Campus Communities Inc]]></category>
		<category><![CDATA[Boston Scientific Corporation]]></category>
		<category><![CDATA[BSX]]></category>
		<category><![CDATA[CMS]]></category>
		<category><![CDATA[CMS Energy Corporation]]></category>
		<category><![CDATA[Edwards Lifesciences Corporation]]></category>
		<category><![CDATA[EW]]></category>
		<category><![CDATA[MDT]]></category>
		<category><![CDATA[Medtronic Inc]]></category>
		<category><![CDATA[NCA]]></category>
		<category><![CDATA[Nuveen California Municipal Value Fund Inc]]></category>
		<category><![CDATA[STS]]></category>
		<category><![CDATA[Supreme Industries Inc]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=84430</guid>
		<description><![CDATA[Edwards Lifesciences (EW) received a major setback as the Centers for Medicare &#38; Medicaid Services (CMS) decided to initiate a National Coverage Analysis (NCA) of transcatheter aortic valve replacement (TAVR). As a result, the stock price of the company closed 6.58% lower on Thursday. According to the agency, it received a formal national coverage determination (NCD) request from the Society of Thoracic Surgeons (STS) and the American College of Cardiology (ACC). Edwards, a leading player in the field of heart valves and hemodynamic monitoring, issued a statement regarding the matter. The company was aware that CMS was considering initiating an NCA to decide on the reimbursement status of Sapien transcatheter heart valve (THV). Besides, it believes that a well-written NCD should ultimately be positive for patients. Current investor focus is ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/10/02/ew-edwards-lifesciences-sapien-under-centers-for-medicare-medicaid-services-nca/84430/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(DNDN) Dendreon Analyst Maintains Neutral on Shares</title>
		<link>http://www.stockbloghub.com/2011/09/14/dndn-dendreon-analyst-maintains-neutral-on-shares/82376</link>
		<comments>http://www.stockbloghub.com/2011/09/14/dndn-dendreon-analyst-maintains-neutral-on-shares/82376#comments</comments>
		<pubDate>Wed, 14 Sep 2011 16:42:37 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[CMS]]></category>
		<category><![CDATA[CMS Energy Corporation]]></category>
		<category><![CDATA[Dendreon Corporation]]></category>
		<category><![CDATA[DNDN]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[MDVN]]></category>
		<category><![CDATA[Medivation Inc]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=82376</guid>
		<description><![CDATA[We have maintained a Neutral rating on Dendreon Corporation (DNDN) with a target price of $13 per share after appraisal of the second quarter 2011 results. Dendreon Corporation reported weaker-than-expected second quarter 2011 sales of $49.6 million of its potential blockbuster prostate cancer vaccine Provenge, though up from prior quarters. Revenues also disappointed the Zacks Consensus Estimate of $59 million in the second quarter. Management surmised that though the physician interest in the vaccine remains solid, its uptake will be slow and gradual. Subsequently, the company withdrew its revenue guidance for the drug, sending its share price down sharply. Provenge is the first product in a new therapeutic class known as &#8220;active cellular immunotherapies.&#8221; We believe that Provenge is capable of changing the paradigm of cancer care dramatically. Provenge is ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/09/14/dndn-dendreon-analyst-maintains-neutral-on-shares/82376/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(WAG) Walgreen Joins U.S. Cardiac Program</title>
		<link>http://www.stockbloghub.com/2011/09/14/wag-walgreen-joins-u-s-cardiac-program/83168</link>
		<comments>http://www.stockbloghub.com/2011/09/14/wag-walgreen-joins-u-s-cardiac-program/83168#comments</comments>
		<pubDate>Wed, 14 Sep 2011 16:32:43 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Drug Stores]]></category>
		<category><![CDATA[Services]]></category>
		<category><![CDATA[CMS]]></category>
		<category><![CDATA[CMS Energy Corporation]]></category>
		<category><![CDATA[CVS]]></category>
		<category><![CDATA[CVS Caremark Corporation]]></category>
		<category><![CDATA[ESRX]]></category>
		<category><![CDATA[Express Scripts Inc.]]></category>
		<category><![CDATA[Harte-Hanks Inc.]]></category>
		<category><![CDATA[HHS]]></category>
		<category><![CDATA[RAD]]></category>
		<category><![CDATA[Rite Aid Corporation]]></category>
		<category><![CDATA[WAG]]></category>
		<category><![CDATA[Walgreen Company]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=83168</guid>
		<description><![CDATA[Walgreen (WAG), the US Department of Health and Human Services (HHS), the Centers for Disease Control and Prevention (CDC) and the Centers for Medicare and Medicaid Services (CMS) have teamed up in a campaign called Million Hearts Initiative in order to prevent 1 million heart attacks and strokes over 5 years. The consortium that claims heart disease and stroke to be the first and third major causes of death, aims at a coordinated approach to promote the quality of treatment and reduce the associated risk factors. In order to support the campaign, Walgreen decides to involve over 26,000 of its pharmacists or Take Care Health providers who will offer free blood pressure testing and consultation. Walgreen also plans to promote diabetes health testing in November and heart health in February ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/09/14/wag-walgreen-joins-u-s-cardiac-program/83168/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(DNDN) Medicare to Cover Dendreon&#8217;s Provenge</title>
		<link>http://www.stockbloghub.com/2011/07/01/dndn-medicare-to-cover-dendreons-provenge/78214</link>
		<comments>http://www.stockbloghub.com/2011/07/01/dndn-medicare-to-cover-dendreons-provenge/78214#comments</comments>
		<pubDate>Fri, 01 Jul 2011 20:36:35 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[CMS]]></category>
		<category><![CDATA[CMS Energy Corporation]]></category>
		<category><![CDATA[Dendreon Corporation]]></category>
		<category><![CDATA[DNDN]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[MDVN]]></category>
		<category><![CDATA[Medivation Inc]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=78214</guid>
		<description><![CDATA[Dendreon Corporation (DNDN) has of late been announcing significant milestones, related to its potential blockbuster cancer vaccine Provenge. Most recently, the company announced that the Centers for Medicare and Medicaid Services (CMS) has agreed to fully reimburse Provenge, an expensive vaccine. CMS is a federal agency that administers the Medicare and Medicaid programs, which provide health care coverage to millions of people in the US. The agency has issued a final National Coverage Decision (NCD) for Provenge which will require Medicare contractors to cover the use of Provenge for treatment of asymptomatic or minimally symptomatic metastatic castrate resistant (hormone refractory) prostate cancer which is consistent with its label. The agency has also issued specific guidelines to local Medicare Administrative Contractors (MACs) to pay for on-label use of Provenge. Provenge is ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/07/01/dndn-medicare-to-cover-dendreons-provenge/78214/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(DNDN) Dendreon Gets FDA Clearance on Second Facility</title>
		<link>http://www.stockbloghub.com/2011/07/01/dndn-dendreon-gets-fda-clearance-on-second-facility/78151</link>
		<comments>http://www.stockbloghub.com/2011/07/01/dndn-dendreon-gets-fda-clearance-on-second-facility/78151#comments</comments>
		<pubDate>Fri, 01 Jul 2011 16:36:18 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[ACI]]></category>
		<category><![CDATA[Arch Coal Inc]]></category>
		<category><![CDATA[CMS]]></category>
		<category><![CDATA[CMS Energy Corporation]]></category>
		<category><![CDATA[Dendreon Corporation]]></category>
		<category><![CDATA[DNDN]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[MDVN]]></category>
		<category><![CDATA[Medivation Inc]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=78151</guid>
		<description><![CDATA[Dendreon Corporation (DNDN) recently received clearance from the U.S. Food and Drug Administration (FDA) to expand manufacturing facility for its cancer vaccine Provenge, in the U.S. The company’s Los Angeles facility can now be operational with 36 workstations. These facilities will be brought online in a staged manner. Earlier, in March 2011, Dendreon’s New Jersey facility received FDA clearance. The facility has 48 workstations, some of which are already operational. The LA and NJ facilities, geared for manufacturing Provenge, now total 84. We believe the expanding manufacturing capacity will significantly increase the availability of Provenge which will help Dendreon to meet pent up demand for the vaccine. The company is also building additional capacity in Atlanta for which the FDA is expected to give its decision in August 2011. All ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/07/01/dndn-dendreon-gets-fda-clearance-on-second-facility/78151/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(CMS) CMS Energy Goes Green in Michigan</title>
		<link>http://www.stockbloghub.com/2011/06/28/cms-cms-energy-goes-green-in-michigan/77653</link>
		<comments>http://www.stockbloghub.com/2011/06/28/cms-cms-energy-goes-green-in-michigan/77653#comments</comments>
		<pubDate>Tue, 28 Jun 2011 16:16:41 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Diversified Utilities]]></category>
		<category><![CDATA[Utilities]]></category>
		<category><![CDATA[AES]]></category>
		<category><![CDATA[AVA]]></category>
		<category><![CDATA[Avista Corporation]]></category>
		<category><![CDATA[CMS]]></category>
		<category><![CDATA[CMS Energy Corporation]]></category>
		<category><![CDATA[The AES Corporation]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=77653</guid>
		<description><![CDATA[Consumers Energy, the major subsidiary of CMS Energy (CMS) has got into an agreement to purchase the total renewable energy output produced by the Fremont Community Digester (“FCD”). The contract is in line with the utility&#8217;s commitment to increase spending in Michigan following the launch of new Pure Michigan Business Connect initiative in early June by the Michigan Economic Development Corporation. CMS Energy will purchase approximately 380,000 megawatt-hours (MWh), or 19,000 MWh per year, of electricity from the FCD over the next 20 years at a cost of $55 million.  The FCD&#8217;s electric output is estimated at 3.1 megawatts. The $22 million digester and electric generator of  FCD is being built by NOVI Energy, Indus Energy and North Central Cooperative, and is expected to begin commercial operation in the summer ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/06/28/cms-cms-energy-goes-green-in-michigan/77653/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(AET) Aetna Gets Approval From Centers for Medicare &amp; Medicaid Services</title>
		<link>http://www.stockbloghub.com/2011/06/16/aet-aetna-gets-approval-from-centers-for-medicare-medicaid-services/76576</link>
		<comments>http://www.stockbloghub.com/2011/06/16/aet-aetna-gets-approval-from-centers-for-medicare-medicaid-services/76576#comments</comments>
		<pubDate>Thu, 16 Jun 2011 21:59:06 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Health Care Plans]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[AET]]></category>
		<category><![CDATA[Aetna Inc.]]></category>
		<category><![CDATA[CI]]></category>
		<category><![CDATA[CIGNA Corporation]]></category>
		<category><![CDATA[CMS]]></category>
		<category><![CDATA[CMS Energy Corporation]]></category>
		<category><![CDATA[Polypore International Inc]]></category>
		<category><![CDATA[PPO]]></category>
		<category><![CDATA[UNH]]></category>
		<category><![CDATA[Unitedhealth Group Inc.]]></category>
		<category><![CDATA[WellPoint Inc.]]></category>
		<category><![CDATA[WLP]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=76576</guid>
		<description><![CDATA[Aetna Inc. (AET) has recently revealed that it has finally got green signal from the Centers for Medicare &#38; Medicaid Services (CMS), to market its Medicare Advantage and Prescription Drug Plan products. In April 2010, the company was banned from offering these products to new members as some of the Medicare prescription drug plans offered between 2009 and 2010 had failed to comply with the regulatory requirements. Aetna’s Medicare products are regulated by the CMS. In April last year, the CMS had granted the company a limited waiver of these sanctions to allow it to continue enrolling eligible members into existing, contracted group Aetna Medicare Advantage Plans and Standalone PDPs through March 31, 2011. Consequently, the company’s 2011 Medicare membership was adversely affected because it did not participate in the 2010 ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/06/16/aet-aetna-gets-approval-from-centers-for-medicare-medicaid-services/76576/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(GD) General Dynamics Gets Follow-on Contract</title>
		<link>http://www.stockbloghub.com/2011/06/04/gd-general-dynamics-gets-follow-on-contract-2/74200</link>
		<comments>http://www.stockbloghub.com/2011/06/04/gd-general-dynamics-gets-follow-on-contract-2/74200#comments</comments>
		<pubDate>Sun, 05 Jun 2011 04:19:07 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Aerospace-Defense Products & Services]]></category>
		<category><![CDATA[Industrial Goods]]></category>
		<category><![CDATA[CMS]]></category>
		<category><![CDATA[CMS Energy Corporation]]></category>
		<category><![CDATA[EMBRAER - Empresa Brasileira de Aeronáutica S.A.]]></category>
		<category><![CDATA[ERJ]]></category>
		<category><![CDATA[Force Protection Inc.]]></category>
		<category><![CDATA[FRPT]]></category>
		<category><![CDATA[GD]]></category>
		<category><![CDATA[General Dynamics Corporation]]></category>
		<category><![CDATA[LMT]]></category>
		<category><![CDATA[Lockheed Martin Corporation]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=74200</guid>
		<description><![CDATA[General Dynamics Information Technology, a business unit of General Dynamics (GD), was awarded a follow-on task order to continue providing claims processing support to the Department of Health and Human Services&#8217; Centers for Medicare and Medicaid Services (CMS). The contract has a total potential value of $95 million spread over a period of five years. Per the contract, General Dynamics will perform computer software services to support the Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) system including maintenance, developmental enhancements and special projects. CMS uses General Dynamics Information Technology&#8217;s ViPS Medicare System software to process approximately 240,000 claims it receives daily. General Dynamics will continue to meet CMS&#8217; objectives by improving the efficiency and effectiveness of claims processing operations and for timely implementation of statutory and regulatory requirements. The ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/06/04/gd-general-dynamics-gets-follow-on-contract-2/74200/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(GD) General Dynamics Gets Follow-on Contract</title>
		<link>http://www.stockbloghub.com/2011/05/28/gd-general-dynamics-gets-follow-on-contract/74287</link>
		<comments>http://www.stockbloghub.com/2011/05/28/gd-general-dynamics-gets-follow-on-contract/74287#comments</comments>
		<pubDate>Sun, 29 May 2011 05:10:44 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Aerospace-Defense Products & Services]]></category>
		<category><![CDATA[Industrial Goods]]></category>
		<category><![CDATA[CMS]]></category>
		<category><![CDATA[CMS Energy Corporation]]></category>
		<category><![CDATA[EMBRAER - Empresa Brasileira de Aeronáutica S.A.]]></category>
		<category><![CDATA[ERJ]]></category>
		<category><![CDATA[Force Protection Inc.]]></category>
		<category><![CDATA[FRPT]]></category>
		<category><![CDATA[GD]]></category>
		<category><![CDATA[General Dynamics Corporation]]></category>
		<category><![CDATA[LMT]]></category>
		<category><![CDATA[Lockheed Martin Corporation]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=74287</guid>
		<description><![CDATA[General Dynamics Information Technology, a business unit of General Dynamics (GD), was awarded a follow-on task order to continue providing claims processing support to the Department of Health and Human Services&#8217; Centers for Medicare and Medicaid Services (CMS). The contract has a total potential value of $95 million spread over a period of five years. Per the contract, General Dynamics will perform computer software services to support the Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) system including maintenance, developmental enhancements and special projects. CMS uses General Dynamics Information Technology&#8217;s ViPS Medicare System software to process approximately 240,000 claims it receives daily. General Dynamics will continue to meet CMS&#8217; objectives by improving the efficiency and effectiveness of claims processing operations and for timely implementation of statutory and regulatory requirements. The ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/05/28/gd-general-dynamics-gets-follow-on-contract/74287/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(DTE) DTE Energy Gets New Partners</title>
		<link>http://www.stockbloghub.com/2011/05/27/dte-dte-energy-gets-new-partners/75116</link>
		<comments>http://www.stockbloghub.com/2011/05/27/dte-dte-energy-gets-new-partners/75116#comments</comments>
		<pubDate>Sat, 28 May 2011 01:05:15 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Electric Utilities]]></category>
		<category><![CDATA[Utilities]]></category>
		<category><![CDATA[BP]]></category>
		<category><![CDATA[BP plc]]></category>
		<category><![CDATA[Chevron Corporation]]></category>
		<category><![CDATA[CMS]]></category>
		<category><![CDATA[CMS Energy Corporation]]></category>
		<category><![CDATA[ConocoPhillips]]></category>
		<category><![CDATA[COP]]></category>
		<category><![CDATA[CVX]]></category>
		<category><![CDATA[DTE]]></category>
		<category><![CDATA[DTE Energy Company]]></category>
		<category><![CDATA[Edison International]]></category>
		<category><![CDATA[EIX]]></category>
		<category><![CDATA[Exxon Mobil Corporation]]></category>
		<category><![CDATA[F]]></category>
		<category><![CDATA[Ford Motor Company]]></category>
		<category><![CDATA[General Motors]]></category>
		<category><![CDATA[GM]]></category>
		<category><![CDATA[WEC]]></category>
		<category><![CDATA[Wisconsin Energy Corporation]]></category>
		<category><![CDATA[XOM]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=75116</guid>
		<description><![CDATA[DTE Energy (DTE) welcomes two new members &#8211; Tesla Motors Inc. (TSLA) and the Electric Power Research Institute (“EPRI”) &#8212; to the electric vehicle research consortium, U.S Driving Research and Innovation for Vehicle efficiency and Energy sustainability (U.S. DRIVE). U.S. DRIVE is a voluntary government-industry partnership focused on research and development of electric vehicles and related infrastructure technology to lower the reliance on fossil fuel. Such projects help to strive for a cleaner environment. The inclusion of these partners will enhance the research network of the consortium. DTE Energy has worked previously with EPRI and developed technologies, which increased the safety and reliability of the electric system infrastructure and reduced the environmental impact of utility operations. Tesla Motors’ ability to create electrical vehicles and its willingness to explore new avenues ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/05/27/dte-dte-energy-gets-new-partners/75116/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(TBT) Finding Income AND Momentum in a Tough Economy</title>
		<link>http://www.stockbloghub.com/2011/05/05/tbt-finding-income-and-momentum-in-a-tough-economy/73320</link>
		<comments>http://www.stockbloghub.com/2011/05/05/tbt-finding-income-and-momentum-in-a-tough-economy/73320#comments</comments>
		<pubDate>Thu, 05 May 2011 17:10:33 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Exchange Traded Fund]]></category>
		<category><![CDATA[Financial]]></category>
		<category><![CDATA[Banco de Chile]]></category>
		<category><![CDATA[Bank of Montreal]]></category>
		<category><![CDATA[BBVA Banco Frances S.A.]]></category>
		<category><![CDATA[BCH]]></category>
		<category><![CDATA[BFR]]></category>
		<category><![CDATA[BMO]]></category>
		<category><![CDATA[BNS]]></category>
		<category><![CDATA[Canadian Imperial Bank of Commerce]]></category>
		<category><![CDATA[CM]]></category>
		<category><![CDATA[CMS]]></category>
		<category><![CDATA[CMS Energy Corporation]]></category>
		<category><![CDATA[economy]]></category>
		<category><![CDATA[FL]]></category>
		<category><![CDATA[Foot Locker Inc.]]></category>
		<category><![CDATA[INTC]]></category>
		<category><![CDATA[Intel Corporation]]></category>
		<category><![CDATA[markets]]></category>
		<category><![CDATA[McGrath Rentcorp]]></category>
		<category><![CDATA[MGRC]]></category>
		<category><![CDATA[Northeast Utilities]]></category>
		<category><![CDATA[NU]]></category>
		<category><![CDATA[Olin Corporation]]></category>
		<category><![CDATA[OLN]]></category>
		<category><![CDATA[PFS]]></category>
		<category><![CDATA[Provident Financial Services Inc]]></category>
		<category><![CDATA[R.R. Donnelley & Sons Company]]></category>
		<category><![CDATA[RCI]]></category>
		<category><![CDATA[Rogers Communications Inc.]]></category>
		<category><![CDATA[Royal Bank of Canada]]></category>
		<category><![CDATA[RRD]]></category>
		<category><![CDATA[RY]]></category>
		<category><![CDATA[TBT]]></category>
		<category><![CDATA[TD]]></category>
		<category><![CDATA[TEF]]></category>
		<category><![CDATA[Telefonica SA]]></category>
		<category><![CDATA[Textainer Group Holdings Limited]]></category>
		<category><![CDATA[TGH]]></category>
		<category><![CDATA[The Bank Of Nova Scotia]]></category>
		<category><![CDATA[Toronto-Dominion Bank]]></category>
		<category><![CDATA[TOT]]></category>
		<category><![CDATA[Total SA]]></category>
		<category><![CDATA[UltraShort 20+ Year Treasury ProShares]]></category>
		<category><![CDATA[Unitrin Inc.]]></category>
		<category><![CDATA[UTR]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=73320</guid>
		<description><![CDATA[With the 10-year T-note yielding only 3.21%, investors interested in getting income from their investments are in sort of a tough place. Dividend-paying stocks are a very good place to look for a replacement. One thing you know for sure is that the coupon payment on a 10-year note is not going to rise. A yield of 3.21% does not offer much of a cushion against inflation. What is inflation likely to average over the next 10 years? I have no idea, but based on the spread between the regular 10-year note, and the 10-year TIPS, the market is implicitly expecting a rate of about 2.50%, which is pretty much in line with the historical experience (headline CPI) over the last 20 years of 2.57%. While core inflation is the ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/05/05/tbt-finding-income-and-momentum-in-a-tough-economy/73320/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(HNT) Health Net First Quarter Report Beats Top Line</title>
		<link>http://www.stockbloghub.com/2011/05/05/hnt-health-net-first-quarter-report-beats-top-line/73292</link>
		<comments>http://www.stockbloghub.com/2011/05/05/hnt-health-net-first-quarter-report-beats-top-line/73292#comments</comments>
		<pubDate>Thu, 05 May 2011 15:48:28 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Health Care Plans]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[CMS]]></category>
		<category><![CDATA[CMS Energy Corporation]]></category>
		<category><![CDATA[Health Net Inc.]]></category>
		<category><![CDATA[HNT]]></category>
		<category><![CDATA[MCR]]></category>
		<category><![CDATA[MFS Charter Income Trust]]></category>
		<category><![CDATA[UNH]]></category>
		<category><![CDATA[Unitedhealth Group Inc.]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=73292</guid>
		<description><![CDATA[Health Net Inc. (HNT) reported first-quarter loss of $108.2 million or a loss per share of $1.16 compared to a net income of $16.1 million or 16 cents in the prior-year quarter. The reported quarter included a $177.2 million pretax or $157.9 million after tax, charge related to the AmCareco litigation and $11.0 million in pretax expenses related to the company’s administrative cost reduction efforts. Health Net&#8217;s Western Region Operations and Government Contracts segments produced combined net earnings of $57.4 million or 61 cents in the reported quarter as opposed to $47.9 million or 47 cents in the prior-year quarter. The improved results were supported by strong commercial and Government Contracts performance, which led to a strong buyback of shares from January 1 through April 29. Health Net reported a ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/05/05/hnt-health-net-first-quarter-report-beats-top-line/73292/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(DTE) DTE Energy Beats Sales &#8211; Misses Earnings Per Share</title>
		<link>http://www.stockbloghub.com/2011/05/03/dte-dte-energy-beats-sales-misses-earnings-per-share/72594</link>
		<comments>http://www.stockbloghub.com/2011/05/03/dte-dte-energy-beats-sales-misses-earnings-per-share/72594#comments</comments>
		<pubDate>Tue, 03 May 2011 19:37:21 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Electric Utilities]]></category>
		<category><![CDATA[Utilities]]></category>
		<category><![CDATA[CMS]]></category>
		<category><![CDATA[CMS Energy Corporation]]></category>
		<category><![CDATA[DTE]]></category>
		<category><![CDATA[DTE Energy Company]]></category>
		<category><![CDATA[WEC]]></category>
		<category><![CDATA[Wisconsin Energy Corporation]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=72594</guid>
		<description><![CDATA[DTE Energy Co. (DTE) announced its first-quarter 2011 operating earnings of $1.11 per share, which fell short of the Zacks Consensus Estimate by a dime. Earnings in the quarter were also lower than $1.38 per share reported in the year-ago period. The year-over-year decline in operating earnings during the first quarter of 2011 was due to lackluster results at Energy Trading, Power and Industrial Projects, and Corporate and Other. GAAP earnings in the quarter were $1.04 per share versus $1.38 per share in the first quarter of 2010. The 7 cent difference between GAAP and operating earnings was due to a one-time adjustment at its Electric Utility segment. Total Revenue Total revenue at DTE Energy at the end of the first quarter was $2,431.0 million versus $2,453.0 million in the ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/05/03/dte-dte-energy-beats-sales-misses-earnings-per-share/72594/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(DNDN) Dendreon Corporation Cuts Loss on Provenge Sales</title>
		<link>http://www.stockbloghub.com/2011/05/03/dndn-dendreon-corporation-cuts-loss-on-provenge-sales/73023</link>
		<comments>http://www.stockbloghub.com/2011/05/03/dndn-dendreon-corporation-cuts-loss-on-provenge-sales/73023#comments</comments>
		<pubDate>Tue, 03 May 2011 18:10:25 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[ACI]]></category>
		<category><![CDATA[Arch Coal Inc]]></category>
		<category><![CDATA[CMS]]></category>
		<category><![CDATA[CMS Energy Corporation]]></category>
		<category><![CDATA[Dendreon Corporation]]></category>
		<category><![CDATA[DNDN]]></category>
		<category><![CDATA[Nidec Corporation]]></category>
		<category><![CDATA[NJ]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=73023</guid>
		<description><![CDATA[Dendreon Corporation’s (DNDN) first quarter 2011 loss (including stock-based compensation expense but excluding other special items) of 69 cents per share was in line with the Zacks Consensus Estimate. Loss was, however, much narrower than the year-ago loss of 94 cents per share, as the company has started generating revenues from its lead advanced prostate cancer vaccine Provenge, which was absent in the prior-year quarter. Quarterly Details Total revenue in the reported quarter climbed to $28.1 million (entirely from Provenge) from $21,000 in the comparable quarter of 2009. The jump was attributable to the presence of Provenge revenue in the current quarter. Revenues were also up 12.4% over the sequentially preceding quarter due to increased demand for the vaccine and the recently approved increased capacity utilization. Revenues were slightly below ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/05/03/dndn-dendreon-corporation-cuts-loss-on-provenge-sales/73023/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(DNDN) Dendreon Learns Medicare May Pay for Provenge Prostate Cancer Vaccine</title>
		<link>http://www.stockbloghub.com/2011/04/10/dndn-dendreon-learns-medicare-may-pay-for-provenge-prostate-cancer-vaccine/70376</link>
		<comments>http://www.stockbloghub.com/2011/04/10/dndn-dendreon-learns-medicare-may-pay-for-provenge-prostate-cancer-vaccine/70376#comments</comments>
		<pubDate>Mon, 11 Apr 2011 02:58:36 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[ACI]]></category>
		<category><![CDATA[Arch Coal Inc]]></category>
		<category><![CDATA[AstraZeneca plc]]></category>
		<category><![CDATA[AZN]]></category>
		<category><![CDATA[CMS]]></category>
		<category><![CDATA[CMS Energy Corporation]]></category>
		<category><![CDATA[Dendreon Corporation]]></category>
		<category><![CDATA[DNDN]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[MDVN]]></category>
		<category><![CDATA[Medivation Inc]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=70376</guid>
		<description><![CDATA[Dendreon Corporation (DNDN) received a huge boost today when the Centers for Medicare and Medicaid Services (CMS) proposed to pay for its lead prostate cancer vaccine Provenge. Provenge was approved in the US in April last year and is marketed since May 2010. It is currently reimbursed by all 15 local Medicare contractors. CMS issued the proposed decision memo for Dendreon’s potential blockbuster vaccine, Provenge, after conducting a scientific review of the evidence provided. The agency believes there is enough evidence to justify reimbursement for the approved label of the vaccine. CMS believes Provenge leads to improvement in health outcomes for men with advanced, castrate-resistant prostate cancer (CRPC) and is clinically necessary, as per CMS. The agency did not propose to cover off-label use of the vaccine at the national ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/04/10/dndn-dendreon-learns-medicare-may-pay-for-provenge-prostate-cancer-vaccine/70376/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(DNDN) Dendreon Analyst Maintains Neutral Rating on Shares</title>
		<link>http://www.stockbloghub.com/2011/04/01/dndn-dendreon-analyst-maintains-neutral-rating-on-shares/70480</link>
		<comments>http://www.stockbloghub.com/2011/04/01/dndn-dendreon-analyst-maintains-neutral-rating-on-shares/70480#comments</comments>
		<pubDate>Fri, 01 Apr 2011 16:17:49 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[AstraZeneca plc]]></category>
		<category><![CDATA[AZN]]></category>
		<category><![CDATA[CMS]]></category>
		<category><![CDATA[CMS Energy Corporation]]></category>
		<category><![CDATA[Dendreon Corporation]]></category>
		<category><![CDATA[DNDN]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[MDVN]]></category>
		<category><![CDATA[Medivation Inc]]></category>
		<category><![CDATA[Nidec Corporation]]></category>
		<category><![CDATA[NJ]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=70480</guid>
		<description><![CDATA[We have maintained our Neutral recommendation on Dendreon Corporation (DNDN) with a target price of $39.00 following the announcement of fourth quarter and full year 2010 financial results. Dendreon’s fourth quarter 2010 loss of 61 cents per share (excluding loss on debt conversion) was wider than the Zacks Consensus Estimate of a loss of 48 cents per share and the year-ago loss of 31 cents per share (excluding gain for warrant revaluation). On a reported basis (including special items), the company lost 64 cents per share in the fourth quarter as against a loss of 28 cents per share in the year-ago quarter. The wider loss was attributable to higher operating expenses as the company is working on expanding its facilities to market Provenge. Dendreon’s lead product is prostate cancer ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/04/01/dndn-dendreon-analyst-maintains-neutral-rating-on-shares/70480/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(HE) Hawaiian Electric Industries Earnings Miss Estimate</title>
		<link>http://www.stockbloghub.com/2011/02/14/he-hawaiian-electric-industries-earnings-miss-estimate/66850</link>
		<comments>http://www.stockbloghub.com/2011/02/14/he-hawaiian-electric-industries-earnings-miss-estimate/66850#comments</comments>
		<pubDate>Mon, 14 Feb 2011 20:29:18 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Electric Utilities]]></category>
		<category><![CDATA[Utilities]]></category>
		<category><![CDATA[CMS]]></category>
		<category><![CDATA[CMS Energy Corporation]]></category>
		<category><![CDATA[Hawaiian Electric Industries Inc]]></category>
		<category><![CDATA[HE]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=66850</guid>
		<description><![CDATA[Hawaiian Electric Industries Inc. (HE) announced fourth-quarter 2010 operating earnings of 26 cents per share, missing both the Zacks Consensus Estimate and the year-ago earnings of 35 cents. The decline in earnings is attributed to weather-driven declines in utility sales. Fiscal 2010 operating earnings came in at $1.21 per share, below the Zacks Consensus Estimate of $1.33. However, this was above fiscal 2009 earnings of $1.12 per share. Operating Statistics Total revenue of the company at the end of the fourth quarter was $695.7 million versus $619.6 million in the year-ago quarter, reflecting growth of 12.3%. Reported results also came higher than the Zacks Consensus Estimate of $580 million. Hawaiian Electric’s reported net income of $24.7 million compared with $13.7 million in the year-ago quarter, helped by higher Bank earnings, ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/02/14/he-hawaiian-electric-industries-earnings-miss-estimate/66850/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(CMS) 21 S&amp;P 500 Companies Are Up More Than 40% Year To Date</title>
		<link>http://www.stockbloghub.com/2010/10/07/cms-21-sp-500-companies-are-up-more-than-40-year-to-date/54300</link>
		<comments>http://www.stockbloghub.com/2010/10/07/cms-21-sp-500-companies-are-up-more-than-40-year-to-date/54300#comments</comments>
		<pubDate>Thu, 07 Oct 2010 23:16:57 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Diversified Utilities]]></category>
		<category><![CDATA[Utilities]]></category>
		<category><![CDATA[AutoZone Inc.]]></category>
		<category><![CDATA[AZO]]></category>
		<category><![CDATA[Centurytel Inc.]]></category>
		<category><![CDATA[CMS]]></category>
		<category><![CDATA[CMS Energy Corporation]]></category>
		<category><![CDATA[CTL]]></category>
		<category><![CDATA[D]]></category>
		<category><![CDATA[Dominion Resources Inc.]]></category>
		<category><![CDATA[Family Dollar Stores Inc.]]></category>
		<category><![CDATA[FDO]]></category>
		<category><![CDATA[PCLN]]></category>
		<category><![CDATA[Priceline.com Inc]]></category>
		<category><![CDATA[SO]]></category>
		<category><![CDATA[Southern Company]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=54300</guid>
		<description><![CDATA[If it seems like every stock you own or watch is breaking out to new highs, you&#8217;re almost right. As the September rally has continued into October, it has pushed 37.4% of the stocks on the S&#38;P 500 to either new 52-week highs or within a fraction of that high. While it is an diverse group of companies, from food companies, to apparel, to integrated oil, to hotels that are hitting new highs, one group stood out from the pack: the utilities. Yes, the one area most investors consider dull and boring actually has been anything but that in recent months. 29 companies, or 15.5%, of those making new highs were in the utilities sector which includes Electric Power, Gas Distribution and the Telephone segment. Who Cares About the Utilities??? ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/10/07/cms-21-sp-500-companies-are-up-more-than-40-year-to-date/54300/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(CSCO) Cisco Systems Aquires ExtendMedia</title>
		<link>http://www.stockbloghub.com/2010/08/29/csco-cisco-systems-aquires-extendmedia/49547</link>
		<comments>http://www.stockbloghub.com/2010/08/29/csco-cisco-systems-aquires-extendmedia/49547#comments</comments>
		<pubDate>Mon, 30 Aug 2010 04:09:48 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Networking & Communication Devices]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[AAPL]]></category>
		<category><![CDATA[Apple Inc.]]></category>
		<category><![CDATA[AT&T Inc.]]></category>
		<category><![CDATA[BCE]]></category>
		<category><![CDATA[Cisco Systems]]></category>
		<category><![CDATA[CMCSA]]></category>
		<category><![CDATA[CMS]]></category>
		<category><![CDATA[CMS Energy Corporation]]></category>
		<category><![CDATA[Comcast Corporation]]></category>
		<category><![CDATA[CSCO]]></category>
		<category><![CDATA[Directv Group Inc]]></category>
		<category><![CDATA[DISH]]></category>
		<category><![CDATA[Dish Network Corporation]]></category>
		<category><![CDATA[DTV]]></category>
		<category><![CDATA[GOOG]]></category>
		<category><![CDATA[Google Inc.]]></category>
		<category><![CDATA[Inc.]]></category>
		<category><![CDATA[Netflix]]></category>
		<category><![CDATA[NFLX]]></category>
		<category><![CDATA[T]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=49547</guid>
		<description><![CDATA[Cisco Systems Inc. (CSCO) has announced its intention to acquire venture capital-funded ExtendMedia, which is a maker of content management system (CMS) software. The deal, which according to some could be worth as much as $80 million, is expected to provide Cisco the necessary technology for delivering video over IP. ExtendMedia’s OpenCase suite (for managing, publishing and monetizing video across platforms) had a few big customers, such as AT&#38;T Corp (T) and Bell Canada &#8211; a subsidiary of BCE Inc (BCE). However, further growth was limited by the non-availability of funds. Consequently, the buyout, which is currently expected to close in the first half of 2011 (subject to regulatory approval), comes at an opportune moment. Video over IP is an extremely hot area, expected to grow very strongly over the ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/08/29/csco-cisco-systems-aquires-extendmedia/49547/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(CMS) Medical Devices Industry Outlook &#8211; August 2010 &#8211; Zacks Analyst Interviews</title>
		<link>http://www.stockbloghub.com/2010/08/25/cms-medical-devices-industry-outlook-august-2010-zacks-analyst-interviews/49243</link>
		<comments>http://www.stockbloghub.com/2010/08/25/cms-medical-devices-industry-outlook-august-2010-zacks-analyst-interviews/49243#comments</comments>
		<pubDate>Wed, 25 Aug 2010 15:14:24 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Diversified Utilities]]></category>
		<category><![CDATA[Utilities]]></category>
		<category><![CDATA[Allscripts-Misys Healthcare Solutions Inc]]></category>
		<category><![CDATA[Boston Scientific Corporation]]></category>
		<category><![CDATA[BSX]]></category>
		<category><![CDATA[CMS]]></category>
		<category><![CDATA[CMS Energy Corporation]]></category>
		<category><![CDATA[CNMD]]></category>
		<category><![CDATA[Conmed Corporation]]></category>
		<category><![CDATA[Cyberonics Inc]]></category>
		<category><![CDATA[CYBX]]></category>
		<category><![CDATA[DES]]></category>
		<category><![CDATA[HAE]]></category>
		<category><![CDATA[Haemonetics Corporation]]></category>
		<category><![CDATA[MDRX]]></category>
		<category><![CDATA[MDT]]></category>
		<category><![CDATA[Medtronic Inc]]></category>
		<category><![CDATA[QSII]]></category>
		<category><![CDATA[Quality Systems Inc.]]></category>
		<category><![CDATA[SMA]]></category>
		<category><![CDATA[St. Jude Medical Inc]]></category>
		<category><![CDATA[STJ]]></category>
		<category><![CDATA[Stryker Corporation]]></category>
		<category><![CDATA[SYK]]></category>
		<category><![CDATA[Symmetry Medical Inc]]></category>
		<category><![CDATA[WisdomTree SmallCap Dividend]]></category>
		<category><![CDATA[Zimmer Holdings Inc]]></category>
		<category><![CDATA[ZMH]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=49243</guid>
		<description><![CDATA[Prelude The global medical devices industry is fairly large, intensely competitive and highly innovative with annual worldwide sales in 2009 in excess of $220 billion. The U.S. accounts for approximately 41% of this market. The industry is divided into different segments such as Cardiology, Oncology, Neuro, Orthopedic, Aesthetic Devices and Healthcare IT (HCIT). The U.S. medical devices industry continues to grow at a brisk rate, thanks to an aging Baby Boomer population, with Neuro, Orthopedic and Aesthetic representing the fastest growing categories. With several growth constraints in the legacy markets, medical devices companies are aiming to expand into lucrative incipient markets. Expansion in the emerging markets, especially those with double-digit annual growth rates, represents one of the best potential avenues for future growth. Our focus in this write up, however, ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/08/25/cms-medical-devices-industry-outlook-august-2010-zacks-analyst-interviews/49243/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(CMS) Medical Devices Industry Outlook &#8211; August 2010 &#8211; Industry Outlook</title>
		<link>http://www.stockbloghub.com/2010/08/24/cms-medical-devices-industry-outlook-august-2010-industry-outlook/49231</link>
		<comments>http://www.stockbloghub.com/2010/08/24/cms-medical-devices-industry-outlook-august-2010-industry-outlook/49231#comments</comments>
		<pubDate>Tue, 24 Aug 2010 22:53:59 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Diversified Utilities]]></category>
		<category><![CDATA[Utilities]]></category>
		<category><![CDATA[Allscripts-Misys Healthcare Solutions Inc]]></category>
		<category><![CDATA[Boston Scientific Corporation]]></category>
		<category><![CDATA[BSX]]></category>
		<category><![CDATA[CMS]]></category>
		<category><![CDATA[CMS Energy Corporation]]></category>
		<category><![CDATA[CNMD]]></category>
		<category><![CDATA[Conmed Corporation]]></category>
		<category><![CDATA[Cyberonics Inc]]></category>
		<category><![CDATA[CYBX]]></category>
		<category><![CDATA[DES]]></category>
		<category><![CDATA[HAE]]></category>
		<category><![CDATA[Haemonetics Corporation]]></category>
		<category><![CDATA[MDRX]]></category>
		<category><![CDATA[MDT]]></category>
		<category><![CDATA[Medtronic Inc]]></category>
		<category><![CDATA[QSII]]></category>
		<category><![CDATA[Quality Systems Inc.]]></category>
		<category><![CDATA[SMA]]></category>
		<category><![CDATA[St. Jude Medical Inc]]></category>
		<category><![CDATA[STJ]]></category>
		<category><![CDATA[Stryker Corporation]]></category>
		<category><![CDATA[SYK]]></category>
		<category><![CDATA[Symmetry Medical Inc]]></category>
		<category><![CDATA[Zimmer Holdings Inc]]></category>
		<category><![CDATA[ZMH]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=49231</guid>
		<description><![CDATA[Prelude The global medical devices industry is fairly large, intensely competitive and highly innovative with annual worldwide sales in 2009 in excess of $220 billion. The U.S. accounts for approximately 41% of this market. The industry is divided into different segments such as Cardiology, Oncology, Neuro, Orthopedic, Aesthetic Devices and Healthcare IT (HCIT). The U.S. medical devices industry continues to grow at a brisk rate, thanks to an aging Baby Boomer population, with Neuro, Orthopedic and Aesthetic representing the fastest growing categories. With several growth constraints in the legacy markets, medical devices companies are aiming to expand into lucrative incipient markets. Expansion in the emerging markets, especially those with double-digit annual growth rates, represents one of the best potential avenues for future growth. Our focus in this write up, however, ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/08/24/cms-medical-devices-industry-outlook-august-2010-industry-outlook/49231/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(GDP) Alternative Energy Stock Review &#8211; May 2010 &#8211; Industry Outlook</title>
		<link>http://www.stockbloghub.com/2010/05/24/gdp-alternative-energy-stock-review-may-2010-industry-outlook/38232</link>
		<comments>http://www.stockbloghub.com/2010/05/24/gdp-alternative-energy-stock-review-may-2010-industry-outlook/38232#comments</comments>
		<pubDate>Tue, 25 May 2010 03:43:13 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Basic Materials]]></category>
		<category><![CDATA[Independent Oil & Gas]]></category>
		<category><![CDATA[Allegheny Energy Inc.]]></category>
		<category><![CDATA[AYE]]></category>
		<category><![CDATA[China Sunergy Company Limited]]></category>
		<category><![CDATA[CMS]]></category>
		<category><![CDATA[CMS Energy Corporation]]></category>
		<category><![CDATA[CSUN]]></category>
		<category><![CDATA[DTE]]></category>
		<category><![CDATA[DTE Energy Company]]></category>
		<category><![CDATA[ESLR]]></category>
		<category><![CDATA[Evergreen Solar Inc.]]></category>
		<category><![CDATA[First Solar]]></category>
		<category><![CDATA[FSLR]]></category>
		<category><![CDATA[GDP]]></category>
		<category><![CDATA[Goodrich Petroleum Corporation]]></category>
		<category><![CDATA[Inc.]]></category>
		<category><![CDATA[JA Solar Holdings Company Limited]]></category>
		<category><![CDATA[JASO]]></category>
		<category><![CDATA[Pepco Holdings]]></category>
		<category><![CDATA[POM]]></category>
		<category><![CDATA[Rentech]]></category>
		<category><![CDATA[RTK]]></category>
		<category><![CDATA[SPWRA]]></category>
		<category><![CDATA[Sunpower Corporation]]></category>
		<category><![CDATA[UIL]]></category>
		<category><![CDATA[UIL Holdings Corporation]]></category>
		<category><![CDATA[Unitil Corporation]]></category>
		<category><![CDATA[UTL]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=38232</guid>
		<description><![CDATA[OUTLOOK The Alternative Energy industry is going through a recovery after emerging from the global recession and the cascading fall in global crude oil prices. Last year, quite a few alternative energy companies were in the trough. And although these companies have recovered from their lows, their valuations still remain attractive. The growth of alternative energy companies is closely tied to the fortunes of the economy. Despite some lingering concerns, particularly in the wake of the European sovereign debt issue, the global economic expansion remains on track. The outlook for the U.S. and key emerging markets remains positive. In the first quarter of fiscal 2010, the U.S. Gross Domestic Product (GDP) grew 3.2%, while sale of electricity to the industrial sector, per the Energy Information Administration (EIA) Incorporatedreased by 2.7% ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/05/24/gdp-alternative-energy-stock-review-may-2010-industry-outlook/38232/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(CMS) CMS Energy Earnings Report Tops Estimates</title>
		<link>http://www.stockbloghub.com/2010/03/03/cms-cms-energy-earnings-report-tops-estimates/29466</link>
		<comments>http://www.stockbloghub.com/2010/03/03/cms-cms-energy-earnings-report-tops-estimates/29466#comments</comments>
		<pubDate>Wed, 03 Mar 2010 23:49:07 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Diversified Utilities]]></category>
		<category><![CDATA[Utilities]]></category>
		<category><![CDATA[CMS]]></category>
		<category><![CDATA[CMS Energy Corporation]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=29466</guid>
		<description><![CDATA[CMS Energy Corporation’s (CMS) fourth-quarter earnings of 38 cents pushed past the Zacks Consensus EPS estimate of 36 cents and 30 cents in the prior-year quarter. The company clocked an EPS of $1.26 in fiscal 2009 compared to the Zacks Consensus Estimate of $1.24. Fiscal 2009 EPS also topped EPS of $1.21 in fiscal 2008. Operational Results Revenue fell to $1.6 billion in the reported quarter from $1.8 billion in the year-ago quarter due to a tepid economy affecting the demand for electricity. The falling trend was witnessed in fiscal 2009 results as well, where revenue fell to $6.2 billion from $6.8 billion in fiscal 2008. On a GAAP basis, CMS Energy reported a net income of $218 million, or 91 cents per share, for fiscal 2009, compared to a ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/03/03/cms-cms-energy-earnings-report-tops-estimates/29466/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(CMS) CMS Energy Raises Dividend by 20%</title>
		<link>http://www.stockbloghub.com/2010/02/01/cms-cms-energy-raises-dividend-by-20/26614</link>
		<comments>http://www.stockbloghub.com/2010/02/01/cms-cms-energy-raises-dividend-by-20/26614#comments</comments>
		<pubDate>Mon, 01 Feb 2010 22:50:22 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Diversified Utilities]]></category>
		<category><![CDATA[Utilities]]></category>
		<category><![CDATA[Calpine Corporation]]></category>
		<category><![CDATA[CMS]]></category>
		<category><![CDATA[CMS Energy Corporation]]></category>
		<category><![CDATA[CPN]]></category>
		<category><![CDATA[Empresa Nacional de Electricidad S.A.]]></category>
		<category><![CDATA[EOC]]></category>
		<category><![CDATA[NI]]></category>
		<category><![CDATA[Nisource Inc.]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=26614</guid>
		<description><![CDATA[CMS Energy (CMS) has raised the quarterly dividend on its common stock by 20% to 15 cents per share, up from 12.5 cents per share. This action has increased the annualized dividend from 50 cents to 60 cents. The first incremental quarterly dividend for the common stock is payable on February 26, 2010, to shareholders of record as of February 8, 2010. CMS Energy has a strong balance sheet among its peers with a low debt-to-capitalization of 70.4% (Zacks industry average was 79.3%) for the first nine months of fiscal 2009. The company continues to be a strong cash generator with an annual operating cash flow of approximately $559 million during fiscal 2008. CMS Energy had $980 million of liquidity Incorporatedluding $797 million under secured credit facilities, and $183 million ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/02/01/cms-cms-energy-raises-dividend-by-20/26614/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(CMS) CMS Energy Issues Senior Notes</title>
		<link>http://www.stockbloghub.com/2010/01/12/cms-cms-energy-issues-senior-notes/24744</link>
		<comments>http://www.stockbloghub.com/2010/01/12/cms-cms-energy-issues-senior-notes/24744#comments</comments>
		<pubDate>Tue, 12 Jan 2010 22:40:10 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Diversified Utilities]]></category>
		<category><![CDATA[Utilities]]></category>
		<category><![CDATA[Calpine Corporation]]></category>
		<category><![CDATA[CMS]]></category>
		<category><![CDATA[CMS Energy Corporation]]></category>
		<category><![CDATA[CPN]]></category>
		<category><![CDATA[Empresa Nacional de Electricidad S.A.]]></category>
		<category><![CDATA[EOC]]></category>
		<category><![CDATA[NI]]></category>
		<category><![CDATA[Nisource Inc.]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=24744</guid>
		<description><![CDATA[CMS Energy (CMS) sold $300 million of senior unsecured notes, due 2020 at a coupon rate of 6.25%. The company plans to use the proceeds to retire existing long-term debt. CMS Energy has a strong balance sheet among its peers with a low debt-to-capitalization of 70.4% (Zacks industry average was 79.3%) for the first nine months of fiscal 2009. The company continues to be a strong cash generator with annual operating cash flow of approximately $559 million during fiscal 2008. CMS Energy had $980 million of liquidity Incorporatedluding $797 million under secured credit facilities, and $183 million in cash and cash equivalents as of Sept 30, 2009. CMS Energy plans to spend $6.3 billion between 2009 and 2013 on base capital investments. This includes maintenance capital expenditures and environmental upgrades, ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/01/12/cms-cms-energy-issues-senior-notes/24744/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(TSON) TranS1 Reports Preliminary Revenues</title>
		<link>http://www.stockbloghub.com/2010/01/08/tson-trans1-reports-preliminary-revenues/24515</link>
		<comments>http://www.stockbloghub.com/2010/01/08/tson-trans1-reports-preliminary-revenues/24515#comments</comments>
		<pubDate>Fri, 08 Jan 2010 20:05:02 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[CMS]]></category>
		<category><![CDATA[CMS Energy Corporation]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[MDT]]></category>
		<category><![CDATA[Medtronic Inc]]></category>
		<category><![CDATA[Stryker Corporation]]></category>
		<category><![CDATA[SYK]]></category>
		<category><![CDATA[TranS1 Inc]]></category>
		<category><![CDATA[TSON]]></category>
		<category><![CDATA[Zimmer Holdings Inc]]></category>
		<category><![CDATA[ZMH]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=24515</guid>
		<description><![CDATA[TranS1 Inc. (TSON) has reported preliminary revenues for the fourth quarter of 2009. Revenues are expected to be approximately in the range of $6.2 million to $6.3 million, lower than the company’s previous guidance of $6.7 million to $7.2 million. The company expects to report its full fourth quarter results in late February 2010. TranS1 has lowered its guidance on revenues due to concerns in the market regarding reimbursement for its AxiaLIF procedure. The company is addressing these issues through continuous education and support resources for its current and prospective surgeon users. TranS1 is also negotiating with the Centre for Medicare and Medicaid (CMS) and different private payors to settle these issues. TranS1 is a medical device company focused on designing, developing and marketing products that use its proprietary minimally ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/01/08/tson-trans1-reports-preliminary-revenues/24515/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(IART) Integra LifeSciences Holdings Enters into New Contract</title>
		<link>http://www.stockbloghub.com/2009/12/11/iart-integra-lifesciences-holdings-enters-into-new-contract/22633</link>
		<comments>http://www.stockbloghub.com/2009/12/11/iart-integra-lifesciences-holdings-enters-into-new-contract/22633#comments</comments>
		<pubDate>Fri, 11 Dec 2009 22:29:17 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[CMS]]></category>
		<category><![CDATA[CMS Energy Corporation]]></category>
		<category><![CDATA[IART]]></category>
		<category><![CDATA[Integra LifeSciences Holdings Corporation]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[MDT]]></category>
		<category><![CDATA[Medtronic Inc]]></category>
		<category><![CDATA[Stryker Corporation]]></category>
		<category><![CDATA[SYK]]></category>
		<category><![CDATA[WMGI]]></category>
		<category><![CDATA[Wright Medical Group Inc]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=22633</guid>
		<description><![CDATA[Integra LifeSciences Holdings Corp. (IART) recently entered into a new three year contract with Premier Purchasing Partners, LLP for Luxtec surgical headlights, light sources and accessories. Integra is a contract supplier of Luxtec surgical vision systems. Financial terms of the contract have not been disclosed. Integra uses its direct sales organization and distributor network to sell Luxtec products. Luxtec is one of the global leaders in surgical vision systems, which are used by thousands of surgeons across the globe. Premier Purchasing Partners is the group purchasing unit of one of the largest healthcare alliances in the US. The Premium healthcare alliance has more than 2,200 hospitals in the U.S. and 63,000-plus other healthcare sites. These hospitals and healthcare sites work together with the objective of improving the quality of healthcare ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/12/11/iart-integra-lifesciences-holdings-enters-into-new-contract/22633/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(HUM) Humana Expands Medicare Coverage in California</title>
		<link>http://www.stockbloghub.com/2009/10/09/hum-humana-expands-medicare-coverage-in-california/17319</link>
		<comments>http://www.stockbloghub.com/2009/10/09/hum-humana-expands-medicare-coverage-in-california/17319#comments</comments>
		<pubDate>Fri, 09 Oct 2009 17:42:03 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Health Care Plans]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[AET]]></category>
		<category><![CDATA[Aetna Inc.]]></category>
		<category><![CDATA[CI]]></category>
		<category><![CDATA[CIGNA Corporation]]></category>
		<category><![CDATA[CMS]]></category>
		<category><![CDATA[CMS Energy Corporation]]></category>
		<category><![CDATA[HUM]]></category>
		<category><![CDATA[Humana Inc.]]></category>
		<category><![CDATA[UNH]]></category>
		<category><![CDATA[Unitedhealth Group]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=17319</guid>
		<description><![CDATA[Recently Humana Inc. (HUM) announced that its Medicare coverage in 3 California countries is expanding. Members eligible for Medicare in Fresno , San Bernardino and Riverside can enroll in a Humana Gold Plus health maintenance organization (HMO) plan. Coverage would be effective from Jan. 1, 2010. The expansion has been approved by the Centers for Medicare &#38; Medicaid Services (CMS). The gold plus plan acts as a supplemental coverage to Medicare. Members can choose a primary care physician in the plan network. The other benefits of the plan include no or low monthly plan premiums, low co-payments for visits to doctors and annual routine physicals, coverage for most annual screenings at no charge, and worldwide emergency coverage. The persons opting for this plan will enjoy discounts on vision and hearing ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/10/09/hum-humana-expands-medicare-coverage-in-california/17319/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

